Cargando…

Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease

BACKGROUND: Patients suffering from Parkinson's disease (PD) display cognitive and neuropsychiatric dysfunctions, especially with disease progression. Although these impairments have been reported to impact more heavily upon a patient's quality of life than any motor dysfunctions, there ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lelos, M.J., Morgan, R.J., Kelly, C.M., Torres, E.M., Rosser, A.E., Dunnett, S.B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academic Press 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801014/ https://www.ncbi.nlm.nih.gov/pubmed/26851542 http://dx.doi.org/10.1016/j.expneurol.2016.02.003

Ejemplares similares

Impaired cognitive and motor function are coincident with l-DOPA-induced dyskinesia in a model of Parkinson’s disease
por: Lelos, Mariah J., et al.
Publicado: (2023)

Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson’s Disease
por: Rees, Daniel, et al.
Publicado: (2022)

Delayed Dopamine Dysfunction and Motor Deficits in Female Parkinson Model Mice
por: Chen, Yuan-Hao, et al.
Publicado: (2019)

Rethinking Functional Outcome Measures: The Development of a Novel Upper Limb Token Transfer Test to Assess Basal Ganglia Dysfunction
por: Clinch, Susanne P., et al.
Publicado: (2018)

Effects of dopamine on reinforcement learning in Parkinson’s disease depend on motor phenotype
por: van Nuland, Annelies J, et al.
Publicado: (2020)

Potential cellular and regenerative approaches for the treatment of Parkinson’s disease
por: Lane, Emma L, et al.
Publicado: (2008)

Cognitive training modifies disease symptoms in a mouse model of Huntington's disease
por: Yhnell, Emma, et al.
Publicado: (2016)

Transplantation site influences the phenotypic differentiation of dopamine neurons in ventral mesencephalic grafts in Parkinsonian rats
por: Fjodorova, Marija, et al.
Publicado: (2017)

Defining the unknowns for cell therapies in Parkinson's disease
por: Lane, Emma L., et al.
Publicado: (2022)

Impaired dopamine release in Parkinson’s disease
por: Cramb, Kaitlyn M L, et al.
Publicado: (2023)

Associations of striatal dopamine transporter binding with motor and non‐motor symptoms in early Parkinson's disease
por: Yang, Zhengjie, et al.
Publicado: (2023)

Mindfulness for Motor and Nonmotor Dysfunctions in Parkinson's Disease
por: Dissanayaka, Nadeeka N. W., et al.
Publicado: (2016)

Cell-penetrating, antioxidant SELENOT mimetic protects dopaminergic neurons and ameliorates motor dysfunction in Parkinson's disease animal models
por: Alsharif, Ifat, et al.
Publicado: (2020)

Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson’s Disease
por: Kirkeby, Agnete, et al.
Publicado: (2017)

The Amphetamine Induced Rotation Test: A Re-Assessment of Its Use as a Tool to Monitor Motor Impairment and Functional Recovery in Rodent Models of Parkinson’s Disease
por: Björklund, Anders, et al.
Publicado: (2019)

Do foetal transplant studies continue to be justified in Huntington’s disease?
por: Bartley, Oliver J.M., et al.
Publicado: (2021)

Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease
por: Chung, Su Jin, et al.
Publicado: (2016)

Reduced striatal dopamine release during motor skill acquisition in Parkinson’s disease
por: Kawashima, Shoji, et al.
Publicado: (2018)

Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
por: Fiorenzato, Eleonora, et al.
Publicado: (2021)

Sexual dysfunction precedes motor defects, dopaminergic neuronal degeneration, and impaired dopamine metabolism: Insights from Drosophila model of Parkinson’s disease
por: Koza, Zevelou, et al.
Publicado: (2023)

Protein-Restricted Diets for Ameliorating Motor Fluctuations in Parkinson's Disease
por: Wang, Luxi, et al.
Publicado: (2017)

Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson’s disease by regulating gut microbiota
por: Zhang, Yi, et al.
Publicado: (2023)

CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease
por: Saunders, Jessica A. Hutter, et al.
Publicado: (2012)

Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson’s Disease
por: Jing, Xiao-Zhong, et al.
Publicado: (2023)

Subthalamic beta bursts correlate with dopamine-dependent motor symptoms in 106 Parkinson’s patients
por: Lofredi, Roxanne, et al.
Publicado: (2023)

Reversal of pathological motor behavior in a model of Parkinson’s disease by striatal dopamine uncaging
por: Zamora-Ursulo, Miguel A., et al.
Publicado: (2023)

Pomegranate Juice Ameliorates Dopamine Release and Behavioral Deficits in a Rat Model of Parkinson’s Disease
por: Kujawska, Małgorzata, et al.
Publicado: (2021)

Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
por: Iarkov, Alexandre, et al.
Publicado: (2020)

Long-Term Motor Cortical Electrical Stimulation Ameliorates 6-Hydroxydopamine-Induced Motor Dysfunctions and Exerts Neuroprotective Effects in a Rat Model of Parkinson’s Disease
por: Kuo, Chi-Wei, et al.
Publicado: (2022)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson’s iPSC-derived dopamine neurons
por: Zambon, Federico, et al.
Publicado: (2019)

Dopaminergic Progenitors Derived From Epiblast Stem Cells Function Similarly to Primary VM-Derived Progenitors When Transplanted Into a Parkinson’s Disease Model
por: Precious, Sophie V., et al.
Publicado: (2020)

Motor Dysfunction Questionnaire and Dopamine Transporter Imaging Composite Scale Improve Differentiating Dementia With Lewy Bodies From Alzheimer's Disease With Motor Dysfunction
por: Chiu, Pai-Yi, et al.
Publicado: (2021)

Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit
por: Tozzi, Alessandro, et al.
Publicado: (2021)

Dopamine Replacement Modulates Oscillatory Coupling Between Premotor and Motor Cortical Areas in Parkinson's Disease
por: Herz, Damian Marc, et al.
Publicado: (2014)

Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota
por: Wang, Yan, et al.
Publicado: (2021)

Polymorphisms in dopamine‐associated genes and cognitive decline in Parkinson's disease
por: Bäckström, D., et al.
Publicado: (2017)

Bee venom phospholipase A2 ameliorates motor dysfunction and modulates microglia activation in Parkinson's disease alpha-synuclein transgenic mice
por: Ye, Minsook, et al.
Publicado: (2016)

Dopamine Receptors and Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2011)

Intracerebroventricular dopamine for Parkinson's disease
por: Devos, David, et al.
Publicado: (2017)

Exercise Ameliorates Motor Deficits and Improves Dopaminergic Functions in the Rat Hemi-Parkinson’s Model
por: Chen, Yuan-Hao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_durq7ii9hvasvmkbr3hgjs31n5